Related Experiment Video
Updated: Aug 3, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Insights
Local hospitals providing optimal treatment regimens for childhood leukemia match survival rates of specialized centers. Improving local care is key, not concentrating all leukemia treatment in a few facilities.
Area of Science:
- Pediatric Oncology
- Health Services Research
Background:
- Childhood leukemia treatment is complex and resource-intensive.
- Care delivery models vary, with some children treated locally and others at specialized centers.
- Evaluating the effectiveness of different care settings is crucial for optimizing outcomes.
Purpose of the Study:
- To compare the medical care and outcomes for children with leukemia treated at local hospitals versus specialized centers.
- To assess survival rates, social, psychological, satisfaction, and cost outcomes across different treatment settings.
- To inform regional healthcare policies for childhood leukemia management.
Main Methods:
- Review of medical care for a population-based sample of children with leukemia 2-3 years post-diagnosis.
- Categorization of local hospitals based on therapeutic regimens used.
- Comparison of outcomes between children treated at local hospitals and specialized leukemia treatment centers.
Main Results:
- Over half of children received treatment at local hospitals; the remainder were referred to specialized centers.
- Survival rates for children receiving optimal regimens at local hospitals were comparable to those at two of three specialized centers.
- No significant differences were observed in social, psychological, satisfaction, or cost outcomes between the groups.
Conclusions:
- Improving therapeutic regimens at local hospitals is a viable strategy for childhood leukemia care.
- Regional policies should focus on enhancing local treatment capabilities rather than solely concentrating care at specialized centers.
- Decentralized, high-quality local care can achieve outcomes equivalent to specialized centers for childhood leukemia.
Abstract:
The medical care given to a population-based sample of children with leukaemia was reviewed between two to three years after diagnosis. Just over half the children had been treated at local hospitals, and the others referred to centres specialising in treatment of leukaemia. Local hospitals could be divided according to the therapeutic regimen used; the survival of children given optimal regimens at local hospitals was equivalent to that of two of the three special centres. Assessment of social, psychological, satisfaction or cost outcomes showed no difference between the groups. It is concluded that a regional policy for childhood leukaemia should be concerned to improve treatment regimens at local hospitals rather than attempt to concentrate care at a few centres.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells
Treatment Resistent Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...